This post was originally published on this site
GSK PLC UK:GSK on Wednesday reported net profit and sales that beat expectations but declined on-year, and backed its guidance for the full year 2023.
The British pharma giant said that first-quarter sales were hit by lower Covid-19 solutions sales compared with the same quarter of 2022. Operating profit and earnings per share were lower due to the previous year’s income benefit of the Gilead settlement and higher sales of Covid-19 treatment Xevudy.
GSK’s…
